Pomerantz Roger
CIK: 0001614936
Director
Primary company: Seres Therapeutics, Inc. (MCRB)
Pomerantz Roger is a corporate insider at Seres Therapeutics, Inc. (MCRB) filing SEC Form 4 transactions. 162 transactions across 6 companies, totaling $3,296 in purchases and $19,581,140 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 30,000 | - | - | 30,000 | 6/10/2025 Filed: 6/11/2025 | Filing → | |
| Disposition | 250 | $0.50 | $125 | 0 | 4/10/2025 Filed: 4/11/2025 | Filing → | |
| Disposition | 250 | $0.50 | $125 | 0 | 4/10/2025 Filed: 4/11/2025 | Filing → | |
| Disposition | 500 | $0.50 | $250 | 0 | 4/10/2025 Filed: 4/11/2025 | Filing → | |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 18,069 | 11/25/2024 Filed: 11/27/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 126,478 | 11/25/2024 Filed: 11/27/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 27,103 | 8/25/2024 Filed: 9/12/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 117,444 | 8/25/2024 Filed: 9/12/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Award | 18,750 | - | - | 18,750 | 6/20/2024 Filed: 6/24/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Award | 50,000 | - | - | 50,000 | 6/20/2024 Filed: 6/24/2024 | Filing → |
| Award | 30,000 | - | - | 30,000 | 6/6/2024 Filed: 6/7/2024 | Filing → | |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,035 | - | - | 36,137 | 5/25/2024 Filed: 5/29/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,035 | - | - | 108,410 | 5/25/2024 Filed: 5/29/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 45,172 | 2/25/2024 Filed: 2/27/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | - | - | 99,375 | 2/25/2024 Filed: 2/27/2024 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | $0.00 | $0 | 54,206 | 11/25/2023 Filed: 11/28/2023 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | $0.00 | $0 | 90,341 | 11/25/2023 Filed: 11/28/2023 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | $0.00 | $0 | 63,240 | 8/25/2023 Filed: 8/29/2023 | Filing → |
Viracta Therapeutics, Inc. VIRX | Exercise | 9,034 | $0.00 | $0 | 81,307 | 8/25/2023 Filed: 8/29/2023 | Filing → |
Viracta Therapeutics, Inc. VIRX | Award | 15,000 | $0.00 | $0 | 15,000 | 8/16/2023 Filed: 8/18/2023 | Filing → |
Type
Award
Shares
30,000
Price
-
Value
-
Type
Disposition
Shares
250
Price
$0.50
Value
$125
Type
Disposition
Shares
250
Price
$0.50
Value
$125
Type
Disposition
Shares
500
Price
$0.50
Value
$250
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Award
Shares
18,750
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Award
Shares
50,000
Price
-
Value
-
Type
Award
Shares
30,000
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,035
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,035
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
-
Value
-
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
$0.00
Value
$0
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
$0.00
Value
$0
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
$0.00
Value
$0
Viracta Therapeutics, Inc.
VIRX
Type
Exercise
Shares
9,034
Price
$0.00
Value
$0
Viracta Therapeutics, Inc.
VIRX
Type
Award
Shares
15,000
Price
$0.00
Value
$0
AI Agent
Try asking...